European Companies Search Engine

EU funding (€6,583,216): Rituximab in patients with acute myocardial infarction: a phase 2 placebo-controlled randomised clinical trial Hor22 Jan 2021 EU Research and Innovation programme "Horizon"

Overview

Text

The filing refers to a past date, and does not necessarily reflect the current state.

Creative Commons License The visualizations for "Assistance Publique Hopitaux de Paris - EU funding (€6,583,216): Rituximab in patients with acute myocardial infarction: a phase 2 placebo-controlled randomised clinical trial" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.